Shen Y - Search Results

1

Individualised cancer therapeutics: dream or reality? Therapeutics construction.

Shen Y, Senzer N, Nemunaitis J. Shen Y, et al. Expert Opin Biol Ther. 2005 Nov;5(11):1427-41. doi: 10.1517/14712598.5.11.1427. Expert Opin Biol Ther. 2005. PMID: 16255647 Review.

2

Herpes simplex virus 1 (HSV-1) for cancer treatment.

Shen Y, Nemunaitis J. Shen Y, et al. Cancer Gene Ther. 2006 Nov;13(11):975-92. doi: 10.1038/sj.cgt.7700946. Epub 2006 Apr 7. Cancer Gene Ther. 2006. PMID: 16604059 Review.

3

Proof concept for clinical justification of network mapping for personalized cancer therapeutics.

Nemunaitis J, Senzer N, Khalil I, Shen Y, Kumar P, Tong A, Kuhn J, Lamont J, Nemunaitis M, Rao D, Zhang YA, Zhou Y, Vorhies J, Maples P, Hill C, Shanahan D. Nemunaitis J, et al. Among authors: shen y. Cancer Gene Ther. 2007 Aug;14(8):686-95. doi: 10.1038/sj.cgt.7701057. Epub 2007 Jun 1. Cancer Gene Ther. 2007. PMID: 17541424

4

Fighting cancer with vaccinia virus: teaching new tricks to an old dog.

Shen Y, Nemunaitis J. Shen Y, et al. Mol Ther. 2005 Feb;11(2):180-95. doi: 10.1016/j.ymthe.2004.10.015. Mol Ther. 2005. PMID: 15668130 Free article. Review.

5

Individualised cancer therapeutics: dream or reality?

Senzer N, Shen Y, Hill C, Nemunaitis J. Senzer N, et al. Among authors: shen y. Expert Opin Ther Targets. 2005 Dec;9(6):1189-201. doi: 10.1517/14728222.9.6.1189. Expert Opin Ther Targets. 2005. PMID: 16300470 Review.

6

Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.

Zhang YA, Nemunaitis J, Samuel SK, Chen P, Shen Y, Tong AW. Zhang YA, et al. Among authors: shen y. Cancer Res. 2006 Oct 1;66(19):9736-43. doi: 10.1158/0008-5472.CAN-06-1617. Cancer Res. 2006. PMID: 17018633

7

Tumor vasculature is a key determinant for the efficiency of nanoparticle-mediated siRNA delivery.

Li L, Wang R, Wilcox D, Zhao X, Song J, Lin X, Kohlbrenner WM, Fesik SW, Shen Y. Li L, et al. Among authors: shen y. Gene Ther. 2012 Jul;19(7):775-80. doi: 10.1038/gt.2011.146. Epub 2011 Sep 29. Gene Ther. 2012. PMID: 21956688 Free PMC article.

8

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.

Bazan-Peregrino M, Carlisle RC, Hernandez-Alcoceba R, Iggo R, Homicsko K, Fisher KD, Halldén G, Mautner V, Shen Y, Seymour LW. Bazan-Peregrino M, et al. Among authors: shen y. Hum Gene Ther. 2008 Sep;19(9):873-86. doi: 10.1089/hum.2008.047. Hum Gene Ther. 2008. PMID: 18710328

9

Non-lethal sonodynamic therapy inhibits high glucose and palmitate-induced macrophage inflammasome activation through mtROS-DRP1-mitophagy pathway.

Wang J, Shen Y, Chen H, Guan J, Li Z, Liu X, Guo S, Wang L, Yan B, Jin C, Li H, Guo T, Sun Y, Zhang W, Zhang Z, Tian Y, Tian Z. Wang J, et al. Among authors: shen y. FASEB J. 2024 Nov 30;38(22):e70178. doi: 10.1096/fj.202402008R. FASEB J. 2024. PMID: 39556373

10

Microvascular decompression for abducens nerve palsy associate with neurovascular conflict.

Zhang Z, Zhang Y, Tang Y, Shen Y, Li Y, Li S, Zhao H. Zhang Z, et al. Among authors: shen y. Neurosurg Rev. 2024 Nov 18;47(1):854. doi: 10.1007/s10143-024-03091-8. Neurosurg Rev. 2024. PMID: 39556262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,004 results

Search Page

Filters